BridgeMD
New treatment option for Advance Care Planning
Official title Advanced Care Planning for the Severely Ill Home-dwelling Elderly
ClinicalTrials.gov ID: NCT05681585
What this study is testing
- What it's testing
- This study will develop and evaluate a complex intervention to implement advance care planning for severely ill home-dwelling elderly acutely admitted to hospital, by using a cluster randomized design. Twelve Norwegian acute geriatric hospital units will participate in the main study, each as one cluster.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 70 and older
You may be able to join if
- Inclusion and
You likely can't join if
- for patients and relatives the quantitative and triadic sub-study: Inclusion criteria for patients:
- Home-dwelling
- 70 years or older
- Acutely admitted to the participating unit
- Sufficient language proficiency in Norwegian to answer the questionnaire
- Clinical frailty score of 4 or more
See the full eligibility criteria
- Inclusion and
- for patients and relatives the quantitative and triadic sub-study: Inclusion criteria for patients:
- Home-dwelling
- 70 years or older
- Acutely admitted to the participating unit
- Sufficient language proficiency in Norwegian to answer the questionnaire
- Clinical frailty score of 4 or more
- The physician responsible for the patient's medical care answers "no" to "Surprise question" from Gold Standards Framework proactive identification guidance
- Both patient and a close relative (preferably the closest relative) would participate in ACP together if offered
- Both patient and the close relative consent to participate in the research project Exclusion criteria for patients:
- The patient is not competent to consent to research participation
- The patient is expected to die within 24 hours
- The patient has participated in ACP prior to the current hospital admission
- In the intervention arm
- ACP is not conducted with patient, next of kin and physician before hospital discharge
- The clinician that participated in the ACP conversation has not consented to research participation
- In the control arm
- The patient would not have been able to participate in ACP during hospitalization
- An attending clinician has not consented to research participation Inclusion criteria for relatives:
- A close relative of a patient who fulfill all inclusion criteria and no exclusion criteria; and who would be willing to participate in ACP together with the patient if offered
- 18 years or older
- Sufficient language proficiency in Norwegian to answer the questionnaire
- Both patient and the close relative consent to participate in the research project Exclusion criteria for relatives:
- The relative is not competent to consent to research participation
- In the intervention arm
- ACP is not carried out with the patient, next of kin and attending clinician before hospital discharge
- In the control arm
- The relative would not have been able to participate in ACP during hospitalization
The study team makes the final eligibility decision.
Where it's taking place
- Oslo, Bærum kommune, Norway
- Arendal, Norway
- Drammen, Norway
- Elverum, Norway
- Gjøvik, Norway
- Kongsberg, Norway
- Kristiansand, Norway
- Lørenskog, Norway
- Oslo, Norway
- Sarpsborg, Norway
- Tønsberg, Norway
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 70 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oslo, Bærum kommune, Norway; Arendal, Norway; Drammen, Norway; Elverum, Norway; Gjøvik, Norway; Kongsberg, Norway and 5 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.